MRF operating with a reduced team

01 Apr 2020
MRF operating with a reduced team

In these unprecedented times caused by coronavirus (COVID-19), Meningitis Research Foundation (MRF) has taken the difficult decision to temporarily reduce the size of our available team, and some services will regrettably be paused or delayed as a consequence.

Some staff members have been placed on the government’s job retention scheme, known as ‘furloughed’ leave.  Please bear with us if it takes us longer to respond to you during this time.

We will continue to provide support through our website, helpline, email and online chat – and we will provide support for those with ongoing fundraising initiatives where we can.

This decision has been necessary because, as elsewhere in the charity sector, fundraising income will drop significantly over the coming months now that many major public-facing fundraising events have been postponed or cancelled for the time being. Because of this, we need to make sure that the resources we have see us through this difficult time. This will put us in the best place to defeat meningitis when things return to normal.

"We plan to continue our full operations as soon as our programme of activities can be restarted."

As our supporters know, MRF has been working to defeat meningitis for over 30 years and we are in this for the long run. Sadly, sometimes that means making difficult choices to secure our future and this is one of those moments.

Pausing some work and placing staff members on the governments job retention scheme is the best way to help protect MRF from the long-term financial implications of the coronavirus pandemic.

We plan to continue our full operations as soon as our programme of activities can be restarted.

Thank you for your understanding and ongoing support throughout this period.

If you have a question or concern about meningitis, contact our support helpline

The MRF Membership and Support team are here for you for any questions you might have about meningitis and septicaemia and their effects on you or your family and friends.

You don’t need to face meningitis and sepsis alone
MRF Chief Executive Vinny Smith explains how we're going to defeat meningitis by 2030.
Give researchers the clues to help defeat meningitis
Give researchers the clues to help defeat meningitis
£160/€190/$214 decodes the genetic information in a sample of meningococcal bacteria. This information helps us to track new forms of meningitis and campaign to introduce new vaccines.
Media contact
Elaine Devine - Director of Advocacy, Communications & Support
Tel: 0333 405 6248